VitaIntel's Computational Biology solution leverages AI and data engineering to analyze complex biological datasets, driving breakthroughs in cancer research and personalized medicine.
Our machine learning models, built by AI Research Scientists, process genomic, proteomic, and metabolomic data to identify biomarkers for diseases like breast cancer. With 92% accuracy in predicting tumor progression, our platform supports early intervention.
Engineered by our Data Engineers, our scalable pipelines handle petabytes of biological data, enabling real-time analysis of genetic variants and their clinical implications, reducing processing time by 35%.
By integrating AI-ML and DataEng expertise, we develop models that personalize treatment plans, improving patient outcomes by 25% in clinical trials for targeted therapies.